BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma
Clinical trial NCT05538988 · WITHDRAWN
Trial details
- NCT number
- NCT05538988
- Sponsor
- AHS Cancer Control Alberta
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.